Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progress and challenges in Mesothelioma: From bench to bedside.

Respiratory medicine - 1 Jan 2018

Blyth Kevin G, Murphy Daniel J

Abstract excerpt

Malignant Pleural Mesothelioma (MPM) is currently an incurable cancer with a typical survival of 1 year from the time of diagnosis. The recent genomic and transcriptomic characterization of MPM presents new opportunities and challenges for MPM researchers. Recent advances in clinical and laboratory diagnostics, and proposals for an updated, data-driven, staging system, also present new challenges for clinicians...

Topics

Biomarkers, Tumor
Biopsy
Humans
Lung Neoplasms
Magnetic Resonance Imaging
Mesothelioma
Mesothelioma, Malignant
Mutation
Neoplasm Staging
Positron Emission Tomography Computed Tomography
Translational Research, Biomedical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29413505
DOI: 10.1016/j.rmed.2017.11.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progress and challenges in Mesothelioma: From bench to bedside.PMID 29413505Read ↗

Genomics and Functional Genomics of Malignant Pleural MesotheliomaSemantic proximity Read ↗

Towards a Better Understanding of Mesothelioma: A Comprehensive Review of Diagnosis, Therapy and BiomarkersSemantic proximity Read ↗

Genomics and Epigenetics of Malignant MesotheliomaSemantic proximity Read ↗

Redefining mesothelioma types as a continuum uncovers the immune and vascular systems as key players in the diagnosis and prognosis of this diseaseSemantic proximity Read ↗

Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.Semantic proximity Read ↗

Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic AlterationsSemantic proximity Read ↗

[Malignant pleural mesothelioma: 2013 state of the art].Semantic proximity Read ↗

Molecular analyses of malignant pleural mesotheliomaSemantic proximity Read ↗

A molecular phenotypic map of Malignant Pleural MesotheliomaSemantic proximity Read ↗

Molecular pathogenesis of malignant mesotheliomaSemantic proximity Read ↗

Integrating Data from Multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort studySemantic proximity Read ↗

Discovery of new biomarkers for malignant mesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.